Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X ...

Illumina, Inc. (NASDAQ:ILMN) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Illumina, Inc.

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein ...

It’s been nearly 15 years since San Diego’s Illumina gained supremacy in DNA sequencing — with just a few rivals competing to deliver the equipment and chemistry to map the genome. But that ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and ...

Illumina, the leading producer of gene-sequencing machines, announced Sunday that it would sell Grail, a cancer test developer that it purchased for $7.1 billion in 2021. The move came two days ...

Illumina introduced gene-sequencing machines that it says can more-than-double capacity and slash the cost of sequencing, as it faces competition and price pressures.

Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs. Skip to main ...